Post by
Akia1818 on Mar 09, 2021 4:45am
Waitingggg !!!
The Concerned Shareholders have identified many actions by Dr. Raza Bokhari and other board members, Stephen Buyer, Robert Ciaruffoli, James Datin, Gerald Goldberg and Larry Kaiser, that have harmed shareholders. Among these is the issuance of at least 13,196,764 of Class B shares in just seven weeks – over 68% of the number outstanding on January 4, 2021, the date of the Concerned Shareholders' requisition of a shareholder meeting (the "Requisition Date"). These entirely unjustified issuances at a time when the Class B shares were already devalued have driven the share price to all-time lows and compounded shareholder losses.
Comment by
Borat138 on Mar 09, 2021 4:55am
This post has been removed in accordance with Community Policy
Comment by
Akia1818 on Mar 09, 2021 6:12am
The Company plans to use all net income to fund future growth opportunities, including acquisitions and developments, financing its capital costs or for operational or corporate capital needs and, in particular, pursuing its ultra-micronized-palmoyl R&D program's short term objectives ("FSD201").